Take a close look at your documentation in these six areas of OB/GYN to start making improvements now and better prepare for ICD-10-CM.
Every specialty will have its own unique changes and challenges with the transition to ICD-10-CM. In the ICD-10-CM manual, there are many new requirements for OB/GYNs. In large part, they require increased specificity. As a result, providers may need to take a good look at their documentation and start making changes now if it isn’t up to these standards.
These are several key examples to help show how the documentation and coding will changes for OB/GYNs in ICD-10-CM. Since much of this relies of the level of detail in the documentation, you can start now. There is no reason to wait. The sooner you start improving documentation the better.
To become familiar with the other codes that may be common in your practice, be sure to do code mapping of your top 50 or so ICD-9-CM codes to their ICD-10-CM equivalents. This will give you a chance not only to get familiar with the new codes but also to look at what other detail might need to be included in your documentation.
If you find that your documentation is really lacking detail and you are not sure how to improve it in preparation for ICD-10-CM, consider hiring a documentation improvement specialist to work with you ahead of the October 1 deadline. Your bank account will thank you for the extra effort!
- Michelle Cavanaugh, RN, CPC, CANPC, CGIC, CPB, CMRS, is an American Health Information Management Association approved ICD-10-CM trainer, certified coder, certified professional biller, and certified medical reimbursement specialist at Kareo.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More